We are live on
!
Find out more
CWM
CIBC World Markets Portfolio holdings
AUM
$20.8B
This Fund
S&P 500
This Quarter
Est. Return
-3.31%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$12.7B
AUM Growth
-$4.36B
(-26%)
Cap. Flow
-$3.8B
Cap. Flow
% of AUM
-29.89%
Top 10 Holdings %
Top 10 Hldgs %
38.21%
Holding
1,893
New
568
Increased
757
Reduced
513
Closed
51
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$211M |
| 2 |
Crown Castle
CCI
|
+$52.2M |
| 3 |
Tesla
TSLA
|
+$46.6M |
| 4 |
XP
XP
|
+$25.2M |
| 5 |
EA
Electronic Arts
EA
|
+$22.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$587M |
| 2 |
Honeywell
HON
|
+$142M |
| 3 |
Mastercard
MA
|
+$126M |
| 4 |
Apple
AAPL
|
+$111M |
| 5 |
Meta Platforms (Facebook)
META
|
+$111M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.12% |
| 2 | Financials | 11.86% |
| 3 | Consumer Discretionary | 10.19% |
| 4 | Communication Services | 9.97% |
| 5 | Healthcare | 7.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1676
MaxCyte
MXCT
$123M
| $64.1K | ﹤0.01% |
+23,481
| New | +$92.6K |
|
1677
Aldeyra Therapeutics
ALDX
$95.3M
| $63.6K | ﹤0.01% |
+11,054
| New | +$65.3K |
|
1678
Aveanna Healthcare
AVAH
$2.05B
| $62.9K | ﹤0.01% |
+11,597
| New | +$54.7K |
|
|
LPRO
1679
DELISTED
Open Lending Corp
LPRO
| $62.6K | ﹤0.01% |
+22,674
| New | +$113K |
|
1680
3D Systems Corp
DDD
$616M
| $60.9K | ﹤0.01% |
28,734
+16,811
| +141% | +$57.1K |
|
1681
Nano X Imaging
NNOX
$72.4M
| $60.9K | ﹤0.01% |
+12,184
| New | +$84.3K |
|
|
ESPR
1682
DELISTED
Esperion Therapeutics
ESPR
| $60.4K | ﹤0.01% |
41,928
+24,245
| +137% | +$44.7K |
|
1683
Aura Biosciences
AURA
$818M
| $60.3K | ﹤0.01% |
+10,292
| New | +$77.9K |
|
1684
Health Catalyst
HCAT
$129M
| $60.2K | ﹤0.01% |
+13,279
| New | +$70.3K |
|
1685
DocGo
DCGO
$61.3M
| $59.6K | ﹤0.01% |
+22,566
| New | +$90.5K |
|
1686
Digital Turbine
APPS
$1.69B
| $58.8K | ﹤0.01% |
+21,648
| New | +$70.3K |
|
|
BBBY
1687
Bed Bath & Beyond
BBBY
$440M
| $58.7K | ﹤0.01% |
+11,138
| New | +$67.6K |
|
1688
Clean Energy Fuels
CLNE
$357M
| $58.7K | ﹤0.01% |
37,879
+21,903
| +137% | +$55.7K |
|
1689
Navitas Semiconductor
NVTS
$3.6B
| $58.6K | ﹤0.01% |
28,567
+16,760
| +142% | +$48K |
|
|
NXDR
1690
Nextdoor Holdings
NXDR
$967M
| $58.5K | ﹤0.01% |
38,219
+22,100
| +137% | +$49.4K |
|
1691
Vanda Pharmaceuticals
VNDA
$305M
| $58.1K | ﹤0.01% |
+12,649
| New | +$59K |
|
1692
8x8 Inc
EGHT
$335M
| $57.9K | ﹤0.01% |
28,963
+17,000
| +142% | +$43.8K |
|
1693
Microvision
MVIS
$78.7M
| $57.9K | ﹤0.01% |
3,112
+1,799
| +137% | +$37.6K |
|
|
WOOF
1694
DELISTED
VCA Inc.
WOOF
| $57.7K | ﹤0.01% |
+18,906
| New | +$57.7K |
|
1695
Heron Therapeutics
HRTX
$92M
| $57.3K | ﹤0.01% |
26,050
+15,064
| +137% | +$29.2K |
|
1696
ASP Isotopes
ASPI
$555M
| $56.9K | ﹤0.01% |
+12,128
| New | +$60.5K |
|
1697
SIGA Technologies
SIGA
$222M
| $56.3K | ﹤0.01% |
+10,277
| New | +$60.9K |
|
1698
Erasca
ERAS
$6.29B
| $55.9K | ﹤0.01% |
40,782
+23,582
| +137% | +$40.5K |
|
1699
Bit Digital
BTBT
$478M
| $55.8K | ﹤0.01% |
27,621
+16,406
| +146% | +$47.3K |
|
1700
Cerus
CERS
$484M
| $55.7K | ﹤0.01% |
40,038
+23,152
| +137% | +$38.8K |
|
Similar funds
VRS
FAF
BGIM
CIM
PPFA
UOC
FNBT
CIBC World Markets's Q1 2025 Portfolio in Review
As of Q1 2025, CIBC World Markets held 1,893 positions worth $12.7B, down 26% from $17.1B the previous quarter. Its ten largest holdings account for 38% of the portfolio.
CIBC World Markets withdrew a net $3.8B in Q1 2025, closing 51 positions and reducing 513 holdings. Its most notable exit was Apellis Pharmaceuticals, an estimated $41M position sold in full.
By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 29% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, CIBC World Markets opened a new position in XP worth $25.2M.
- CIBC World Markets's largest Q1 2025 buy was XP: 1,832,600 shares worth $25.2M.
- CIBC World Markets added most to Microsoft in Q1 2025, an estimated $211M increase.
- CIBC World Markets's biggest Q1 2025 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $587M.
- CIBC World Markets fully exited Apellis Pharmaceuticals in Q1 2025, selling an estimated $41M.
- CIBC World Markets's ten largest holdings make up 38% of its $12.7B portfolio in Q1 2025.
- CIBC World Markets opened 568 new positions and closed 51 in Q1 2025.
- CIBC World Markets's portfolio value fell 26% quarter-over-quarter to $12.7B.
Based on CIBC World Markets's 13F filing for Q1 2025, filed 13 May 2025.